In Entwicklung
Gesundheit·10 sa önceKI-Zusammenfassung
網購「瘦瘦針」亂象多 食藥署：已下架逾千則違規貼文
俗稱「瘦瘦針」的GLP-1類藥物減重熱潮引發網路販售亂象。民進黨立委林淑芬質詢指出，臉書、Threads等平台仍有大量販售資訊。食藥署表示，截至6月10日已下架1197則違規貼文，今年以來查獲124件違規案件，裁罰355.5萬元，並預告修法強化網路平台責任。
自
自由时报glp-1
Stabil63 Meldungen15 QuellenZuletzt aktualisiert: 10 sa önce
Neueste Meldungen
In Entwicklung
Gesundheit·10 sa önceKI-Zusammenfassung
瘦瘦針網路販售亂象多 食藥署祭出管理與查緝作為
立委林淑芬關注瘦瘦針（GLP-1類藥物）網路販售亂象，食藥署表示，截至6月10日已下架臉書、Threads等平台違規貼文1197則，並自2024年起查獲124件違規案件，累計裁罰355.5萬元，未來將修法強化網路平台責任。
自
自由时报
In Entwicklung
Gesundheit·12 sa önceKI-Zusammenfassung
食藥署研議將瘦瘦針納入入境申報管理，防堵中國非法輸入
針對立委質疑中國瘦瘦針透過社群平台非法輸入，食藥署表示正研議將GLP-1類藥品（瘦瘦針）納入入境申報管理或邊境查核重點，以防堵非法輸入。同時，食藥署也推動修法強化網路平台責任，並呼籲民眾循正規醫療管道就醫。
自
自由时报
In Entwicklung
Gesundheit·22 sa önceKI-Zusammenfassung
Mato Grosso do Sul vai incinerar uma tonelada de emagrecedores ilegais
Uma tonelada de produtos para emagrecimento, incluindo canetas e anabolizantes, será incinerada pela Secretaria de Saúde de MS. Os itens, apreendidos em fiscalizações, eram comercializados sem autorização da Anvisa e representam riscos à saúde.
G
G1
Gesundheit
1 g önceKI-Zusammenfassung
أطعمة تساعد في تنظيم مستويات السكر في الدم
الكربوهيدرات ليست كلها سيئة، فبعض الأطعمة مثل التفاح والفاصوليا والعدس والشوفان والكينوا يمكن أن تساعد في تنظيم مستويات السكر في الدم وخفضها عند تناولها ضمن نظام غذائي متوازن.
ا
الشرق الأوسط
In Entwicklung
Gesundheit·2 g önceKI-Zusammenfassung
أدوية السكري لإنقاص الوزن قد تحسن خصوبة الرجال
أظهرت دراسة حديثة أن أدوية GLP-1، المستخدمة لعلاج السكري وإنقاص الوزن، قد تحسن خصوبة الرجال. شهد الرجال الذين تناولوا هذه الأدوية تحسنًا في مستويات التستوستيرون، وعدد الحيوانات المنوية، وحجمها، وشكلها، مما قد يفتح آفاقًا جديدة لعلاج العقم عند الرجال.
C
CNN بالعربية
NACHRICHT
2 g önceKI-Zusammenfassung
Tempo Meals Review: High-Protein, GLP-1 Friendly Meal Delivery
Tempo Meals, a spin-off from Home Chef, offers prepared, never-frozen meals focusing on high-protein and GLP-1 plans. Meals cost $11-$13, with significant discounts available for new customers and a lifetime discount for military and first responders.
W
Wired
In Entwicklung
Gesundheit·2 g önceKI-Zusammenfassung
GLP-1藥物或改善肥胖男性精液品質與生殖健康
最新臨床研究顯示，GLP-1類藥物除了減重，還可能改善部分肥胖男性的精液品質與生殖健康指標。研究人員強調，藥物並非助孕藥，需更多研究驗證。
自
自由时报
In Entwicklung
Gesundheit·3 g önceKI-Zusammenfassung
Febre dos peptídeos: entenda o que são e quais os riscos
Peptídeos, promovidos como antienvelhecimento e para performance, carecem de comprovação científica e aprovação regulatória no Brasil. Especialistas alertam para riscos de uso sem orientação médica.
G
G1
In Entwicklung
Gesundheit·3 g önceKI-Zusammenfassung
Reposição de medicamentos: O que são e como salvam vidas
O reposicionamento de medicamentos, que consiste em encontrar novos usos para fármacos já existentes, tem se mostrado uma estratégia eficaz e econômica para salvar vidas, especialmente em crises de saúde como a da COVID-19. Medicamentos como a dexametasona e o baricitinibe foram reaproveitados para tratar a inflamação em pacientes com coronavírus, salvando milhares de vidas. A Comissão Europeia planeja expandir essa abordagem para a busca de tratamentos contra o câncer. Exemplos históricos incluem o raloxifeno para prevenção de câncer de mama, a talidomida para mieloma múltiplo e o Viagra (sildenafil) para disfunção erétil, originalmente desenvolvido para doenças cardiovasculares. A tendência de reaproveitamento de medicamentos levanta questões sobre seus verdadeiros prós e contras, cujas respostas podem levar anos para serem totalmente compreendidas.
G
G1
In Entwicklung
Gesundheit·3 g önceKI-Zusammenfassung
Diretrizes médicas priorizam semaglutida e tirzepatida para tratamento da obesidade
Novas diretrizes médicas nos EUA e Brasil priorizam semaglutida e tirzepatida para obesidade, com foco em mudanças de estilo de vida. Documentos organizam drogas por hierarquia e risco cardiovascular, visando melhorar saúde e reduzir mortalidade.
G
G1
In Entwicklung
Gesundheit·5 g önceKI-Zusammenfassung
Ozempic et les parfums gourmands : une nouvelle tendance olfactive ?
Des utilisateurs d'Ozempic et d'autres médicaments amaigrissants rapportent une nouvelle obsession pour les parfums gourmands, certains allant jusqu'à les utiliser comme substituts de repas. D'autres se plaignent d'effets secondaires olfactifs moins agréables.
L
Le Figaro Actualités
In Entwicklung
Gesundheit·5 g önceKI-Zusammenfassung
UK Startup to Trial Cancer Drug to Prevent Life-Threatening Side-Effect
Poolbeg Pharma will trial its oral drug POLB 001 at six NHS hospitals to prevent cytokine release syndrome (CRS), a dangerous side-effect of cancer immunotherapy. The drug could improve patient safety and save healthcare systems millions by allowing treatment outside specialist centers.
G
Guardian UK
In Entwicklung
Gesundheit·6 g önceKI-Zusammenfassung
Drugmakers Envision Future of Obesity Treatments Beyond GLP-1s
Drugmakers are exploring new obesity treatments beyond GLP-1s, including less frequent shots and pills with fewer side effects. Eli Lilly's experimental drug retatrutide showed significant weight loss, while competitors like Novo Nordisk, Structure Therapeutics, AstraZeneca, Pfizer, and Amgen are developing new oral and injectable options. The market is expected to grow significantly, with pricing and insurance coverage being key factors.
C
CNBC US Markets
In Entwicklung
Gesundheit·11.06.2026KI-Zusammenfassung
Drug Repurposing: From Diabetes to Weight Loss and Beyond
The article explores drug repurposing, highlighting GLP-1 agonists like Ozempic and Wegovy, initially for diabetes, now used for weight loss, cardiovascular health, and more. It also discusses COVID-19 treatments like dexamethasone and baricitinib, and historical examples like raloxifene, thalidomide, BCG vaccine, and Viagra, emphasizing both the benefits and potential risks of using drugs for unapproved conditions.
D
Deutsche Welle
NACHRICHT
11.06.2026KI-Zusammenfassung
Zayıflama İlaçları Hanelerin Gıda Alışverişlerini Değiştirdi
Worldpanel by Numerator araştırması, zayıflama ilaçları kullanan hanelerin market harcamalarında 780 milyon sterlin düşüş yaşandığını ortaya koydu. Kullanıcılar daha az ürün alıp, eskiden sevdikleri yiyeceklerden keyif almadıklarını belirtiyor.
A
AA Güncel
Gesundheit
11.06.2026KI-Zusammenfassung
UK Approves Wegovy Weight-Loss Pill, Expanding Obesity Treatment Options
The UK's MHRA has approved Wegovy, the first GLP-1 receptor agonist tablet for weight loss, making the UK the third country to authorize the pills. This expands treatment options for adults with obesity or overweight with related health conditions.
G
Guardian UKGesundheit
11.06.2026KI-Zusammenfassung
UK Approves First GLP-1 Receptor Agonist Tablet for Weight Management
The UK's MHRA has approved the first GLP-1 receptor agonist tablet, semaglutide (Wegovy), for weight loss and management. This daily pill offers a more convenient alternative to weekly injections for adults with obesity or those overweight with weight-related conditions.
T
Times of India
In Entwicklung
Business·11.06.2026KI-Zusammenfassung
Online Pharmacies and GLP-1s: A Growing Market with Troubling Practices
Online telehealth pharmacies are booming, selling GLP-1s and weight-loss drugs. However, many consumers report being charged for unsolicited medications, facing impossible cancellation policies, and experiencing unresponsive customer service, leading to significant financial losses and frustration.
W
Wired
In Entwicklung
Gesundheit·11.06.2026KI-Zusammenfassung
Boehringer Ingelheim's experimental drug shows promise in reducing liver fat
Boehringer Ingelheim's experimental drug, survodutide, has shown significant potential in reducing liver fat accumulation, a condition known as MASLD/MASH. Presented at the American Diabetes Association (ADA) annual meeting, the drug targets both weight loss and metabolic health, offering a new approach beyond traditional obesity treatments.
G
G1In Entwicklung
Gesundheit·10.06.2026KI-Zusammenfassung
أدوية إنقاص الوزن قد تقلل خطر الإصابة ببعض أنواع السرطان
تشير دراسة أمريكية جديدة إلى أن أدوية إنقاص الوزن الحديثة من فئة GLP-1 قد تقلل خطر الإصابة ببعض أنواع السرطان المرتبطة بالسمنة بنسبة تصل إلى 41%، مع انخفاض ملحوظ لدى الرجال وسرطان بطانة الرحم.
د
دويتشه فيله
In Entwicklung
Business·10.06.2026KI-Zusammenfassung
Weight-loss drugs cut UK household grocery bills by £418 annually
GLP-1 weight-loss drug users in Great Britain are saving an average of £418 annually on groceries, with household use nearly tripling in two years to 1.9 million adults. The drugs are impacting food consumption and forcing retailers to adapt.
G
Guardian Business
Gesundheit
10.06.2026KI-Zusammenfassung
GLP-1 Obesity Treatments Show Promise in Reducing Cancer Risk
Recent studies suggest GLP-1 obesity treatments may reduce cancer risk, showing correlation with decreased incidence in 6 out of 7 cancers, potentially through anti-inflammatory effects beyond weight loss.
N
NPR News
In Entwicklung
Gesundheit·04.06.2026KI-Zusammenfassung
New Oral Drug Shows Promise for Type 2 Diabetes Management
Researchers in Beijing have developed a new oral drug, HRS-7535, a GLP-1 receptor agonist, showing significant reductions in HbA1c levels in a Phase 2 trial for type 2 diabetes patients. The drug may offer a simpler alternative to injectable treatments like Ozempic.
R
RT عربي